Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 2011. The document serves as a notification of transactions involving a Person Discharging Managerial Responsibility, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific insider transaction and does not contain consolidated financial statements.
Material Changes
The filing details a transaction by Mr. S M Bicknell on November 9, 2011:
- Exercise of options over 22,500 Ordinary shares granted on December 3, 2002, at a price of £11.79 per share.
- Immediate sale of the 22,500 Ordinary shares at a price of £13.73 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a regulatory disclosure of a director's share transaction.
Investor Verification Points
- Verify the total number of shares held by Mr. S M Bicknell following this transaction.
- Confirm the current share price relative to the £13.73 sale price to assess market timing.
- Review the GlaxoSmithKline Share Option Plan terms regarding the 2002 grant.